This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As one of the first partners of ATI, the biotechnology company hired interns to form a team of data stewards to work on a significant data segmentation project. The programs through ATI are customized to the companies they partner with, offering free technical training that aligns with the organizations skills needs.
Sana Biotechnology CEO Steve Harr cuts the ribbon at the company’s new manufacturing facility in Bothell, Wash., The Bothell facility will house Sana’s proprietary cancer drug program. The diabetes program involves turning stem cells into insulin-producing islet cells. Washington state Rep.
Sana Biotechnology has a new $50 million tool in its toolbox. Gene editing technology is a key component in developing engineered cells as medicines, and we are pleased to have the ability to use the Cas12b system as part of a number of our ex vivo engineered cell programs,” said Steve Harr , Sana’s president and CEO in a statement.
Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. Sana Biotechnology named two new research leaders. Members include: Sonoma co-founder Alexander Rudensky , chair of the immunology program at the Sloan Kettering Institute.
Sana Biotechnology , a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its new biomanufacturing facility. The company currently has multiple pre-clinical programs but has not yet entered a product into clinical trials. (Sana Photo).
Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. The company said it was shutting a program focused on heart failure and outlined reset priorities for other programs. Sana CEO Steve Harr. Sana Photo).
A biotech prize for turning chemicals into food On the biotechnology front, the Mars Society plans to offer an incentive prize for methods that use microbes to convert simple chemicals, such as methane or methanol, into food. “Ask it anything you want, and you get the answer in multiple personalities,” he said.
The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.
Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). Lance Solomon.
The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Three Washington state companies — Sana Biotechnology , Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year.
Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.
It has three clinical programs to treat gastrointestinal diseases including C. Lumen is led by Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts , the former head of basic sciences at the Fred Hutchinson Cancer Research Institute. They co-founded the startup in 2017.
Founder pedigree: Kiem, who is director of the Stem Cell and Gene Therapy Program at the Fred Hutch, and Lieber, a professor with the UW’s Division of Medical Genetics, will be scientific co-founders of Ensoma. In 2019, Kiem gave a TEDxSeattle talk on the science involved.
based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. Seattle Genetics CEO Clay Siegall. Seattle Genetics Photo).
Under the agreement, Takeda has options to exclusively license programs at the preclinical stage and will take products to the clinic and through commercialization. Immusoft’s most advanced therapeutic program is designed to treat a rare enzyme deficiency disorder, Hurler syndrome.
Healthcare Technology is paramount for the healthcare industry, including the medical, pharmaceutical, and biotechnology industries. In order to meet the growing demand for tech talent, companies such as Progressive have invested in internal upskilling bootcamp programs to help close the skills gap.
Quantum computing is at an exciting stage, where active collaboration between academia and industry is leading to rapid innovation, explains Mohit Pandey, a quantum computing scientist who has extensive experience using quantum computing for drug discovery while working in the biotechnology industry. Contact us today to learn more.
Local immunotherapy biotech companies include Umoja Biopharma, Sana Biotechnology, Chinook Therapeutics, Kineta, Alpine Immune Sciences, Adaptive Biotechnologies, and others.
Two others Washington state biotech companies, Absci and Icosavax , have also recently filed to go public, building on IPOs earlier this year from Sana Biotechnology , Impel Neuropharma and Lyell Immunopharma, which is based in South San Francisco and the Seattle area. Eliem’s tech. Via SEC filing).
How many will be accepted into the program? Strella Biotechnology Co-founder and CEO Katherine Sizov won GeekWire’s Elevator Pitch startup competition at the 2022 GeekWire Summit, with a unique sensing technology that reduces food waste by determining what? Steuart Walton. GeekWire story: Scramble the fighters! Amazon’s Treasure Truck.
The program will start in November at the UW. (UW It will host a 9-month program this November for 20-to-25 companies in partnership with Microsoft and the University of Washington’s business, engineering, and computer science schools. “This is the track,” Dooley said.
The technology was developed under DARPA’s Reliable Neural-Interface Technology (RE-NET) program , and offers new potential for safely expanding the use of brain-machine interfaces (BMIs) to treat physical disabilities and neurological disorders.
In Washington state, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies , Neoleukin Therapeutics and Sana Biotechnology all shed employees in 2022. Along with the layoffs, the company is de-prioritizing a program for glioblastoma and a discovery program for blood cancers.
As a result, all business leaders are finding that their roles are expanding with opportunities to drive progressive digital-first programs. Through engaging with employees, leaders can better comprehend which specific processes or programs are hurting productivity and invest in solutions to close those gaps.
Other former positions include leadership roles at the Gates Foundation and directing the global drug development program at PATH. Susan Wyrick of Sana Biotechnology. “It’s been a wonderful ride launching and leading this deep-tech startup mentorship program in Seattle for just over 3 years now.
Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.
The program was shuttered “based on a review of the preliminary data, the expected benefit to risk ratio for patients, and recent developments in the field of IL-2 therapeutics,” according to a November company statement. IL-2 can quell cancer but it can also have toxic effects, which Neoleukin’s protein aimed to to minimize.
The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. A fifth company is the brainchild of a founder previously at Pacific Northwest Research Institute (PNRI).
Andris Zoltners stepped down from the board of publicly traded Seattle-based Adaptive Biotechnologies after 11 years. . Nautilus Biotechnology Photo). Nautilus Biotechnology, a Seattle and Silicon Valley startup led by Isilon co-founder Suja Patel, hired Nick Nelson as chief business officer. Nick Nelson.
He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. Earlier companies are considering fewer development programs and having a slower ramp on hiring. Neoleukin Therapeutics recently shed staff in the wake of disappointing clinical data for its lead program, for example.
Three Seattle-area companies — Sana Biotechnology , Impel Neuropharma, and Paymentus — have gone public with a traditional IPO this year, and Icosovax just filed last week. Last month Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger.
Seattle is known for its strength in cell therapy, notes Modulus chief scientist Max Darnell , with growing biotech companies such as Sana Biotechnology and Lyell Immunopharma, as well as an arm of Bristol Myers Squib. “We want to be this discovery player that can plug into these larger incumbents,” he said.
In addition, Fred Hutchinson Cancer Center would oversee the clinical oncology programs at both the center and UW Medical Center, according to a press release. Under the new arrangement, all SCCA clinical sites would be renamed “Fred Hutchinson Cancer Center.”.
expanding the biotechnology industry in North Carolina, and growing cancer research programs in Georgia. Born in Vancouver, Wash., Alexandre moved to the East Coast where she spent the majority of her career, after completing her doctorate in public health at UCLA. Her work included developing health policy in Washington D.C.,
The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics. It reported $19.3 billion in revenue for 2022, up from $18.5
LinkedIn Photo) Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen has a huge pipeline for early programs and is undisputedly the anchor tenant in Pacific Northwest biotech. William Canestaro. He worked to grow the Bothell, Wash.
“This funding will allow us to build upon our promising preliminary data demonstrating detection of Alzheimer’s disease at its earliest stages and further our preclinical therapeutic program,” Daggett said in a statement. Before COVID-19, AltPrep was housed at the UW’s CoMotion Labs incubator space in Fluke Hall.
He develops tools to help understand massive-scale genomic and biomedical data and has helped generate online learning programs that have enrolled more than 8 million people. I think there’s a lot of room for creativity, especially within the data, machine learning and AI space at the interface between biotechnology and data science.
Other key personnel changes across the Pacific Northwest tech industry: — Adaptive Biotechnologies named Kyle Piskel as its new chief financial officer. Techstars announced one month later that it was shutting down the Seattle program. F5 reported $693 million in revenue for its most recent quarter, down 1% year-over-year.
The program serves tech-focused students in 44 high schools spread across multiple districts north of Seattle. Portia Kibble Smith, head of DEI programs and partnerships at Karat, accepts the Geeks Give Back Award at the 2023 GeekWire Awards. See this post for more background on this category.
healthcare system is complex and places significant strain on consumers, who struggle to effectively use their healthcare and benefits, make informed decisions about their health, and navigate the fragmented network of providers and third-party benefit programs,” the company says in the filing. . “The U.S. Vancouver, Wash.-based
… Read More Meet the 24 new startups in Techstars Seattle, as accelerator doubles class size Startup accelerator program Techstars Seattle on Monday unveiled 24 companies for its 15th cohort, doubling the class size from last year’s dozen graduates. A magnitude 4.3 earthquake struck Sunday evening at 7:21 p.m.
The initiative has support from major Northwest tech companies and provides a free, six-month training program for “board-ready” Black executives. Voluntary programs include OnBoarding Women , a Seattle-based effort started in 2014 to boost the number of women on public boards. Do I wish the change would come faster?”
Montoya is responsible for Equinix’s global cybersecurity risk program. Seattle-based Nautilus Biotechnology appointed Human Protein Atlas Director Emma Lundberg to its scientific advisory board. . — F5 Networks named Equinix Chief Information Security Officer and Microsoft alum Michael Montoya to its board of directors.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content